Skip To Main Content
Richard Barfield on Muck Rack

Richard Barfield

As seen in: PLOS, Science Magazine, BioRxiv, JD Supra, medRxiv, The UK in a Changing Europe, Byline Times
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Richard

Contact Richard, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Maternal Antibodies to Primary CMV Infection Link to Fetal Transmission

|
By Chelsea Crooks, Richard Barfield, Adelaide S Fuller
| medRxiv
S.R.P. serves as a consultant for Pfizer, Merck, Moderna, Dynavax, and Kamada and has led sponsored research programs with Moderna, Pfizer, Dynavax, and Kamada on CMV vaccine development. B.L.H. has received payments from UpToDate and Moderna. G. K. S. is a DSMB member for the Moderna RSV vaccine trial in pregnancy and is an author and contributor to UpToDate. All other authors have no conflicts to disclose.
Open in Who Shared View Duplicates (42) Issue with article?

Identifying correlates of viral rebound timing and viral control in SHIV-infected infant macaques after ART interruption

|
By Veronica Obregon-Perko, Achal Awasthi, Richard Barfield, Stella J Berendam, Bhrugu Yagnik, Greg Tharp, Prachi Gupta, Gloria Mensah, Margaret Neja, Mithra R. Kumar, Emily J. Fray, Fan Bu, Justin Pollara, Marina Tuyishime, Guido Ferrari
| Science Magazine Verified
Editor’s summary To test whether a therapeutic approach for HIV infection could be curative, people living with HIV need to undergo an analytical treatment interruption (ATI) where they stop taking antiretroviral therapy (ART). Although adults can volunteer for such studies, they are ethically tricky to conduct in pediatric populations. Here, Obregon-Perko et al. asked whether a preclinical pediatric nonhuman primate model might offer insights into features associated with viral control.
Open in Who Shared Issue with article?

The pentameric complex is not required for congenital CMV transmission in seronegative rhesus macaques

|
By Hsuan-Yuan Wang, Ning Liu, Xingyuan Hu, Husam Taher, Craig Kreklywich, Kimberli A. Schmidt, Elizabeth Scheef, Richard Barfield, Claire E. Otero, Ke Zhang, Claire Callahan, Francesco Monticolo, Roxanne M. Gilbride, Chelsea Crooks, Yueqing Qiao
| Science Magazine Verified
Editor’s summary Congenital cytomegalovirus (cCMV) infections are a major driver of birth defects and neurodevelopmental delays in human newborns. Thus, strategies to prevent transplacental mother-to-fetus transmission are urgently needed. One proposed strategy is to vaccinate against the viral pentameric complex (PC), a multiglycoprotein complex required for viral entry into nonfibroblast cells in tissue culture. Here, Wang et al.
Open in Who Shared Issue with article?
See all 13 articles